Activation of the alternative complement pathway by lymphoblasts isolated from canine thymic lymphomas

Area of Science:

• Immunology
• Veterinary Medicine
• Oncology

Background:

• Canine thymic lymphomas are a significant health concern in veterinary oncology.
• The complement system, particularly the alternative pathway, plays a crucial role in immune responses and can be implicated in various diseases.

Purpose of the Study:

• To investigate the capacity of lymphocytes from canine thymic lymphomas to activate the alternative complement pathway.
• To compare the complement-activating potential of lymphoma-derived lymphocytes with that of normal canine thymic lymphocytes.

Main Methods:

• Isolation of lymphocytes from canine thymic lymphoma cases and normal canine thymus.
• Assessment of the alternative complement pathway activation by these isolated lymphocytes.
• Evaluation of the effect of trypsinization on the complement-activating ability of lymphoma cells.

Main Results:

• Five out of fourteen canine thymic lymphoma cases exhibited lymphocytes capable of activating the alternative complement pathway.
• Normal canine thymic lymphocytes did not demonstrate the ability to activate this pathway.
• Trypsinization of the lymphoma cells did not abolish their capacity to activate the alternative complement pathway.

Conclusions:

• Certain canine thymic lymphomas possess lymphocytes with the intrinsic ability to activate the alternative complement pathway.
• This complement-activating property is a potential characteristic distinguishing lymphoma cells from normal thymic lymphocytes.
• The mechanism of activation is robust, persisting even after enzymatic cell surface modification.